Drugs by Condition

Insomnia Medications

Definition of Insomnia: Inability to sleep, abnormal wakefulness. More...

Drugs associated with Insomnia

The following drugs and medications are in some way related to, or used in the treatment of Insomnia. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

See sub-conditions

Drug Name ( View by: Brand \| Generic )	Reviews	Ratings
Ambien (Pro, More...) generic name: zolpidem class: miscellaneous anxiolytics, sedatives and hypnotics	84 review(s)	Rate It!	7.7
Ambien CR (More...) generic name: zolpidem class: miscellaneous anxiolytics, sedatives and hypnotics	18 review(s)	Rate It!	7.2
Ativan (Pro, More...) generic name: lorazepam class: benzodiazepine anticonvulsants, benzodiazepines, miscellaneous antiemetics	4 review(s)	Rate It!	7.9
Benadryl (More...) generic name: diphenhydramine class: anticholinergic antiemetics, anticholinergic antiparkinson agents, antihistamines, miscellaneous anxiolytics, sedatives and hypnotics	1 review(s)	Rate It!	9.0
Dalmane (More...) generic name: flurazepam class: benzodiazepines	2 review(s)	Rate It!	9.0
Desyrel (Pro, More...) generic name: trazodone class: phenylpiperazine antidepressants	2 review(s)	Rate It!	6.0
Elavil (More...) generic name: amitriptyline class: tricyclic antidepressants	4 review(s)	Rate It!	7.5
Halcion (Pro, More...) generic name: triazolam class: benzodiazepines	1 review(s)	Rate It!	7.0
Klonopin (Pro, More...) generic name: clonazepam class: benzodiazepine anticonvulsants, benzodiazepines	3 review(s)	Rate It!	7.6
Lunesta (Pro, More...) generic name: eszopiclone class: miscellaneous anxiolytics, sedatives and hypnotics	41 review(s)	Rate It!	7.2
Neurontin (Pro, More...) generic name: gabapentin class: gamma-aminobutyric acid analogs	4 review(s)	Rate It!	8.3
Remeron (Pro, More...) generic name: mirtazapine class: tetracyclic antidepressants	3 review(s)	Rate It!	8.8
Restoril (Pro, More...) generic name: temazepam class: benzodiazepines	6 review(s)	Rate It!	6.2
Rozerem (More...) generic name: ramelteon class: miscellaneous anxiolytics, sedatives and hypnotics	12 review(s)	Rate It!	5.4
Seroquel (Pro, More...) generic name: quetiapine class: atypical antipsychotics	13 review(s)	Rate It!	8.6
Seroquel XR (Pro, More...) generic name: quetiapine class: atypical antipsychotics	1 review(s)	Rate It!	9.0
Sinequan (Pro, More...) generic name: doxepin class: miscellaneous anxiolytics, sedatives and hypnotics, tricyclic antidepressants	1 review(s)	Rate It!	9.0
Sonata (Pro, More...) generic name: zaleplon class: miscellaneous anxiolytics, sedatives and hypnotics	9 review(s)	Rate It!	8.3
Tylenol PM (More...) generic name: acetaminophen/diphenhydramine class: analgesic combinations	1 review(s)	Rate It!	7.3
Zyprexa (More...) generic name: olanzapine class: atypical antipsychotics	2 review(s)	Rate It!	5.3
20 most popular shown. Show all 99...

Insomnia Medications in the Pipeline

Indiplon (NBI-34060)

December 13, 2007 - Neurocrine Receives Approvable Letter for Indiplon Capsules with Additional Safety and Efficacy Data Required by FDA
August 22, 2007 - Neurocrine Announces PDUFA Action Date of December 12, 2007 for Indiplon Capsules
June 13, 2007 - Neurocrine Announces Resubmission of New Drug Application for Indiplon Capsules
September 5, 2006 - Neurocrine Reports Results of FDA End-of-Review Meeting on Indiplon Capsules NDA
June 15, 2006 - Neurocrine Completes Review of Indiplon Action Letters
May 16, 2006 - Neurocrine Receives Approvable Letter for indiplon Capsules and Non-Approvable for indiplon Tablets for the Treatment of Insomnia
July 26, 2005 - Neurocrine Announces Acceptance of New Drug Application for Indiplon Tablets
June 14, 2005 - Neurocrine Announces Acceptance of New Drug Application for Indiplon Capsules
May 26, 2005 - Neurocrine Announces Submission of New Drug Application for Indiplon Tablets
April 14, 2005 - Neurocrine Announces Submission of New Drug Application for Indiplon Capsules
February 7, 2005 - Neurocrine Biosciences Announces Resubmission Status of Indiplon
January 11, 2005 - Neurocrine Biosciences Announces Plans to Resubmit Indiplon Modified Release New Drug Application (NDA)
December 21, 2004 - Indiplon IR NDA (New Drug Application) to Be Reformatted Due to Difficulties in Accessing Portions of the Electronic NDA
November 22, 2004 - Neurocrine Submits New Drug Application (NDA) for Indiplon Modified Release Tablets for the Treatment of Insomnia
October 19, 2004 - Neurocrine Submits New Drug Application (NDA) for Indiplon Immediate Release Capsules for the Treatment of Insomnia

Silenor (doxepin HCl)

July 7, 2009 - Somaxon Announces $6 Million Private Equity Financing and Acceptance of NDA Resubmission of Silenor for the Treatment of Insomnia
June 5, 2009 - Somaxon Resubmits New Drug Application for Silenor (Doxepin) for the Treatment of Insomnia
April 7, 2009 - Somaxon Provides Update on New Drug Application for Silenor (doxepin) for the Treatment of Insomnia
February 27, 2009 - Somaxon Receives Complete Response Letter from the FDA for Silenor (doxepin)
November 24, 2008 - FDA Extends Review of Somaxon Pharmaceuticals' New Drug Application for Silenor (Doxepin) by up to Three Months
April 15, 2008 - Somaxon Pharmaceuticals Announces Acceptance for Filing of New Drug Application for Silenor for the Treatment of Insomnia
January 31, 2008 - Somaxon Pharmaceuticals Submits New Drug Application for Silenor for the Treatment of Insomnia
May 9, 2007 - Somaxon Pharmaceuticals Provides Update on Silenor Development Program
November 20, 2006 - Somaxon Pharmaceuticals’ Silenor Demonstrates Positive Results in its Third Phase 3 Clinical Trial in Insomnia

Intermezzo (zolpidem tartrate)

October 30, 2009 - Transcept Pharmaceuticals Receives Complete Response Letter from FDA on Intermezzo New Drug Application
June 11, 2009 - Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo
December 16, 2008 - Transcept Pharmaceuticals Announces FDA Acceptance for Review of New Drug Application for Intermezzo
October 1, 2008 - Transcept Pharmaceuticals Submits New Drug Application for Intermezzo for Treatment of Middle-of-the-Night Awakenings

Ciltyri (eplivanserin)

September 17, 2009 - Sanofi-Aventis Receives Complete Response Letter from the FDA for eplivanserin (Ciltyri) Submission

Latest Insomnia Blog Post

Stress, Bad Bedtime Habits Cause Insomnia
FRIDAY, July 24 -- Bad bedtime habits can keep you up at night and cause problems during the day, says the head of a Texas sleep study facility. Stress, worry, caffeine, alcohol and watching TV in bed -- factors known as "poor sleep hygiene" -- are the...

View all Insomnia blog posts.

Insomnia Support Group Questions

Go to the Insomnia support group or view all Insomnia questions.

Ask a Question about Insomnia:

Learn more about Insomnia

Medical encyclopedia results for:

Sleeping difficulty

Browse drugs by condition:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

	Search:
Browse all medications A B C D E F G H I J K L M N O P Q R S T U V W X Y Z	Advanced Search